A detailed history of Lion Street Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 2,595 shares of NTRA stock, worth $434,039. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,595
Previous 2,595 -0.0%
Holding current value
$434,039
Previous $281,000 17.08%
% of portfolio
0.12%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$85.28 - $112.6 $221,301 - $292,197
2,595 New
2,595 $281,000
Q2 2023

Jul 28, 2023

BUY
$47.08 - $55.16 $192,792 - $225,880
4,095 New
4,095 $199,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.